Advertisement

Management of the Lateral Neck in Well-Differentiated Thyroid Cancer

  • Richard W. Nason
  • K. Alok Pathak
Part of the Head and Neck Cancer Clinics book series (HNCC)

Abstract

Lymph node metastases to the lateral neck in well-differentiated thyroid cancer (WDTC) do not appear to significantly impact overall survival. They probably do play a role in recurrence- and disease-free survival. As reviewed elsewhere in this monograph the extent of surgical resection should depend on the extent of cancer with the aim to control the cancer and avoid reoperation if possible with minimal morbidity. Management decisions for the lateral neck are based on desire for regional control balanced with complications of surgery. These considerations have driven controversy in both the timing of treatment (elective versus therapeutic neck dissection) and the extent of surgery necessary to control disease. At present, the balance of opinion favours observation or expectant management of the clinically negative lateral neck. The extent of neck dissection for clinically evident disease remains controversial.

Keywords

Neck Dissection Lateral Neck Radical Neck Dissection Accessory Nerve Selective Neck Dissection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Noguchi S, Murakami N. The value of lymph-node dissection in patients with differentiated thyroid cancer. Surg Clin North Am. 1987;67:251–61.PubMedGoogle Scholar
  2. 2.
    Ozaki O, Ito K, Kobayashi K, et al. Modified neck dissection for patients with nonadvanced, differentiated carcinoma of the thyroid. World J Surg. 1988;12:825–9.PubMedCrossRefGoogle Scholar
  3. 3.
    Noguchi M, Kumaki T, Taniya T, et al. Impact of neck dissection on survival in well-differentiated thyroid cancer: a multivariate analysis of 218 cases. Int Surg. 1990;75:220–4.PubMedGoogle Scholar
  4. 4.
    Attie JN, Khafif RA, Steckler RM. Elective neck dissection in papillary carcinoma of the thyroid. Am J Surg. 1971;122:464–71.PubMedCrossRefGoogle Scholar
  5. 5.
    Frankenthaler RA, Sellin RV, Cangir A, et al. Lymph node metastasis from papillary-follicular thyroid carcinoma in young patients. Am J Surg. 1990;160:341–3.PubMedCrossRefGoogle Scholar
  6. 6.
    White ML, Gauger PG, Doherty GM. Central lymph node dissection in differentiated thyroid cancer. World J Surg. 2007;31:895–904.PubMedCrossRefGoogle Scholar
  7. 7.
    Mulla MG, Knoefel WT, Gilbert J, et al. Lateral cervical lymph node metastases in papillary thyroid cancer: a systematic review of imaging-guided and prophylactic removal of the lateral compartment. Clin Endocrinol (Oxf). 2012;77:126–31.CrossRefGoogle Scholar
  8. 8.
    Mazzaferri EL, Young RL, Oertel JE, et al. Papillary thyroid carcinoma: the impact of therapy in 576 patients. Medicine (Baltimore). 1977;56:171–95.CrossRefGoogle Scholar
  9. 9.
    Coburn MC, Wanebo HJ. Prognostic factors and management considerations in patients with cervical metastases of thyroid cancer. Am J Surg. 1992;164:671–6.PubMedCrossRefGoogle Scholar
  10. 10.
    Hamming JF, van de Velde CJ, Fleuren GJ, et al. Differentiated thyroid cancer: a stage adapted approach to the treatment of regional lymph node metastases. Eur J Cancer Clin Oncol. 1988;24:325–30.PubMedCrossRefGoogle Scholar
  11. 11.
    Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery. 1988;104:947–53.PubMedGoogle Scholar
  12. 12.
    Hutter RV, Frazell EL, Foote Jr FW. Elective radical neck dissection: an assessment of its use in the management of papillary thyroid cancer. CA Cancer J Clin. 1970;20:87–93.PubMedCrossRefGoogle Scholar
  13. 13.
    McHenry CR, Rosen IB, Walfish PG. Prospective management of nodal metastases in differentiated thyroid cancer. Am J Surg. 1991;162:353–6.PubMedCrossRefGoogle Scholar
  14. 14.
    Block MA. Management of carcinoma of the thyroid. Ann Surg. 1977;185:133–44.PubMedCentralPubMedCrossRefGoogle Scholar
  15. 15.
    Shah MD, Hall FT, Eski SJ, et al. Clinical course of thyroid carcinoma after neck dissection. Laryngoscope. 2003;113:2102–7.PubMedCrossRefGoogle Scholar
  16. 16.
    Gemsenjäger E, Perren A, Seifert B, et al. Lymph node surgery in papillary thyroid carcinoma. J Am Coll Surg. 2003;197:182–90.PubMedCrossRefGoogle Scholar
  17. 17.
    Wada N, Duh QY, Sugino K, et al. Lymph node metastasis from 259 papillary thyroid microcarcinomas. Frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg. 2003;237:399–407.PubMedCentralPubMedGoogle Scholar
  18. 18.
    Hillel AD, Kroll H, Dorman J, et al. Radical neck dissection: a subjective and objective evaluation of postoperative disability. J Otolaryngol. 1989;18:53–61.PubMedGoogle Scholar
  19. 19.
    Marchetta FC, Sako K, Matsuura H. Modified neck dissection for carcinoma of the thyroid gland. Am J Surg. 1970;120:452–5.PubMedCrossRefGoogle Scholar
  20. 20.
    Crile Jr G. Survival of patients with papillary carcinoma of the thyroid after conservative operations. Am J Surg. 1964;108:862–6.PubMedCrossRefGoogle Scholar
  21. 21.
    Cady B, Sedgwick CE, Meissner WA, et al. Changing clinical, pathologic, therapeutic, and survival patterns in differentiated thyroid carcinoma. Ann Surg. 1976;184:541–53.PubMedCentralPubMedCrossRefGoogle Scholar
  22. 22.
    Sanders LE, Rossi RL. Occult well differentiated thyroid carcinoma presenting as cervical node disease. World J Surg. 1995;19:642–6; discussion 646–7.PubMedCrossRefGoogle Scholar
  23. 23.
    Crile Jr G. Treatment of papillary carcinoma of the thyroid with lateral cervical metastases. Am J Surg. 1950;80:419–23.PubMedCrossRefGoogle Scholar
  24. 24.
    Mazzaferri EL, Young RL. Papillary thyroid carcinoma: a 10-year follow-up report of the impact of therapy in 576 patients. Am J Med. 1981;70:511–8.PubMedCrossRefGoogle Scholar
  25. 25.
    McGregor GI, Luoma A, Jackson SM. Lymph node metastases from well-differentiated thyroid cancer. Am J Surg. 1985;149:610–2.PubMedCrossRefGoogle Scholar
  26. 26.
    Musacchio MJ, Kim AW, Vijungco JD, et al. Greater local recurrence occurs with ‘berry picking’ than neck dissection in thyroid cancer. Am J Surg. 2003;69:191–6; discussion 196–7.Google Scholar
  27. 27.
    Palazzo F, Gosnell J, Savio R, et al. Lymphadenectomy for papillary thyroid cancer: changes in practice over four decades. Eur J Surg Oncol. 2006;32:340–4.PubMedCrossRefGoogle Scholar
  28. 28.
    Bhattacharyya N. Surgical treatment of cervical node metastases in patients with papillary thyroid cancer. Arch Otolaryngol Head Neck Surg. 2003;129:1101–4.PubMedCrossRefGoogle Scholar
  29. 29.
    Turanli S. Is the type of dissection in lateral neck metastases for differentiated thyroid cancer important? Otolaryngol Head Neck Surg. 2007;136:957–60.PubMedCrossRefGoogle Scholar
  30. 30.
    Grant CS, Stulak JM, Thompson B, et al. Risks and adequacy of an optimized surgical approach to the primary surgical management of papillary thyroid carcinoma treated during 1999–2006. World J Surg. 2010;34:1239–46.PubMedCrossRefGoogle Scholar
  31. 31.
    Farrag T, Lin F, Brownlee N, et al. Is routine dissection of level IIb and Va necessary in patients with papillary thyroid cancer undergoing lateral neck dissection for FNA-confirmed metastases in other levels? World J Surg. 2009;33:1680–3.PubMedCrossRefGoogle Scholar
  32. 32.
    Lim YC, Choi EC, Yoon YH. Occult lymph nodes in neck level V in papillary thyroid carcinoma. Surgery. 2010;147:241–5.PubMedCrossRefGoogle Scholar
  33. 33.
    Ahmadi N, Grewal A, Davidson B. Patterns of cervical lymph node metastases in primary and recurrent papillary thyroid cancer. J Oncol. 2011;2011:735678.PubMedCentralPubMedCrossRefGoogle Scholar
  34. 34.
    Caron NR, Tan YY, Ogilvie JB, et al. Selective modified radical neck dissection for papillary thyroid cancer—is level I, II and V dissection always necessary? World J Surg. 2006;30:833–40.PubMedCrossRefGoogle Scholar
  35. 35.
    Stack Jr BC, Ferris RL, Goldenberg D. American Thyroid Association consensus review and statement regarding the anatomy, terminology, and rationale for lateral neck dissection in differentiated thyroid cancer. Thyroid. 2012;22:501–8.PubMedCrossRefGoogle Scholar
  36. 36.
    Nason RW, Abdulrauf BM, Stranc MF. The anatomy of the accessory nerve and cervical lymph node biopsy. Am J Surg. 2000;180:241–3.PubMedCrossRefGoogle Scholar
  37. 37.
    Sivanandan R, Soo KC. Pattern of cervical lymph node metastases from papillary carcinoma of the thyroid. Br J Surg. 2001;88:1241–4.PubMedCrossRefGoogle Scholar
  38. 38.
    Pingpank Jr JF, Sasson AR, Hanlon AL, et al. Tumor above the spinal accessory nerve in papillary thyroid cancer that involves lateral neck nodes. Arch Otolaryngol Head Neck Surg. 2002;128:1275–8.PubMedCrossRefGoogle Scholar
  39. 39.
    Yanir Y, Doweck I. Regional metastases in well-differentiated thyroid carcinoma: pattern of spread. Laryngoscope. 2008;118:433–6.PubMedCrossRefGoogle Scholar
  40. 40.
    Kupferman ME, Weinstock YE, Santillan AA. Predictors of level V metastases in well differentiated thyroid cancer. Head Neck. 2008;30:1469–74.PubMedCrossRefGoogle Scholar
  41. 41.
    Yüce I, Cağli S, Bayram A. Regional metastatic pattern of papillary thyroid carcinoma. Eur Arch Otorhinolaryngol. 2010;267:437–41.PubMedCrossRefGoogle Scholar

Copyright information

© K. Alok Pathak, Richard W. Nason, Janice L. Pasieka, Rehan Kazi, Raghav C. Dwivedi 2015

Authors and Affiliations

  1. 1.Head and Neck Surgical OncologyCancerCare ManitobaWinnipegCanada
  2. 2.Head and Neck Surgical OncologyCancerCare Manitoba, University of ManitobaWinnipegCanada

Personalised recommendations